logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Innovative drug concept stocks continue to be strong, Kangchen Pharmaceuticals has hit the limit up.

date
11/07/2025
Innovative pharmaceutical concept stocks continue to show strength, with Kangchen Pharmaceutical Industry hitting the limit up, Changshan Pharmaceutical Industry and Boteng shares rising by more than 10%, and Lianhuan Pharmaceutical Industry, Shouyao Holdings, and Guangshengtang all rising.
Latest
1 m ago
The Kurdish Workers' Party has transferred the first batch of 30 members to turn in their weapons.
3 m ago
China Beidahuang (00039.HK) will be suspended from trading starting July 11th, awaiting the announcement of the results of the hearing.
3 m ago
Guolian Lifesciences (601456.SH) announces a forecasted increase, expecting the net profit attributable to the parent company in the first half of the year to be approximately 1.129 billion yuan, a year-on-year growth of around 1183%.
3 m ago
Li Lecheng's research on artificial intelligence boosting new industrialization.
7 m ago
FDA rejects muscle disease drug application, Capricor Therapeutics (CAPR.US) plummets in pre-market trading.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.